| JSGZX | VEXPX | JSGZX / VEXPX | |
| Total Expense Ratio | 1.49 | 0.44 | 339% |
| Annual Report Gross Expense Ratio | 1.53 | 0.44 | 348% |
| Fund Existence | 17 years | 58 years | - |
| Gain YTD | 1.629 | 2.114 | 77% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.8B | 20.7B | 14% |
| Annual Yield % from dividends | 0.31 | 0.37 | 84% |
| Returns for 1 year | 0.00 | -5.25 | - |
| Returns for 3 years | 30.68 | 26.46 | 116% |
| Returns for 5 years | -32.55 | -9.59 | 339% |
| Returns for 10 years | 43.07 | 44.75 | 96% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JDITX | 16.70 | 0.02 | +0.12% |
| JHancock Disciplined Value Intl R4 | |||
| WAIGX | 14.80 | 0.01 | +0.07% |
| Wasatch International Growth Investor | |||
| MMNJX | 15.01 | 0.01 | +0.07% |
| MassMutual Small Cap Gr Eq Y | |||
| RYMRX | 20.87 | 0.01 | +0.05% |
| Guggenheim Multi-Hedge Strategies C | |||
| ETNHX | 51.47 | N/A | N/A |
| Eventide Healthcare & Life Sciences N | |||